Status:
COMPLETED
Allograft With Enamel Matrix Derivative Versus Allograft Alone in the Treatment of Intrabony Defects .
Lead Sponsor:
Mansoura University
Conditions:
Intrabony Periodontal Defect
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
Periodontal intrabony defects represent a major challenge for the clinician in periodontal therapy. If left untreated, these defects represent a risk factor for disease progression and additional atta...
Detailed Description
primary goal of periodontal therapy is not arrest the tissue destruction caused periodontal disease only, but also to reconstruct the tissue lost caused by infectious process. Periodontal intrabony de...
Eligibility Criteria
Inclusion
- Age range between 30-50 years.
- Patients with stage III periodontitis, will be diagnosed on the basis of probing pocket depth and clinical attachment loss.
- Presence of at least one or more radiographically detectable intrabony defect with clinical periodontal pocket depth (PPD) ≥5 mm, clinical attachment loss ≥5 mm, and radiographic depth of the intrabony defect ≥3 mm.
- No periodontal therapy within the last 6 months
Exclusion
- Smoker and alcoholic patient.
- Patient with any signs, symptoms or history of systemic disease that might affect the periodontium and interfere with healing process.
- Pregnant patients.
- Patient who has traumatic occlusion.
- Uncooperative patient
Key Trial Info
Start Date :
November 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06041854
Start Date
November 22 2022
End Date
February 22 2024
Last Update
May 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Egypt